Bausch Health Companies Inc.
BHC
$5.71
-$0.18-3.06%
NYSE
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 7.01% | 8.41% | 9.87% | 10.92% | 10.23% |
| Total Other Revenue | 18.18% | 19.79% | 13.83% | 9.68% | 7.61% |
| Total Revenue | 7.13% | 8.53% | 9.91% | 10.91% | 10.20% |
| Cost of Revenue | 7.48% | 8.64% | 8.71% | 10.14% | 8.92% |
| Gross Profit | 6.98% | 8.49% | 10.41% | 11.23% | 10.74% |
| SG&A Expenses | 10.46% | 12.87% | 13.07% | 15.42% | 12.78% |
| Depreciation & Amortization | -3.15% | -1.76% | 0.00% | -0.72% | -5.76% |
| Other Operating Expenses | -66.67% | 200.00% | 200.00% | 0.00% | 0.00% |
| Total Operating Expenses | 6.52% | 8.07% | 8.63% | 9.83% | 7.83% |
| Operating Income | 9.75% | 10.53% | 15.60% | 15.88% | 21.85% |
| Income Before Tax | 179.38% | 158.51% | 142.82% | 93.38% | -1,516.00% |
| Income Tax Expenses | 52.29% | 73.08% | 8.14% | -28.21% | -28.50% |
| Earnings from Continuing Operations | 109.47% | 83.09% | 88.22% | 77.72% | -168.25% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | 38.89% | 70.83% | 36.84% | 254.55% | 1,100.00% |
| Net Income | 120.81% | 91.21% | 92.23% | 81.52% | -153.23% |
| EBIT | 9.75% | 10.53% | 15.60% | 15.88% | 21.85% |
| EBITDA | 4.71% | 5.57% | 8.84% | 8.39% | 9.04% |
| EPS Basic | 120.24% | 91.15% | 92.13% | 81.56% | -152.65% |
| Normalized Basic EPS | 30.76% | 72.62% | 70.25% | 65.19% | 313.61% |
| EPS Diluted | 120.24% | 91.16% | 92.14% | 81.58% | -151.03% |
| Normalized Diluted EPS | 30.95% | 72.61% | 70.24% | 65.17% | 314.11% |
| Average Basic Shares Outstanding | 1.80% | 1.82% | 1.87% | 0.09% | 0.08% |
| Average Diluted Shares Outstanding | 1.80% | 1.81% | 1.87% | 0.09% | 0.02% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |